
    
      Study Objectives:

        -  To compare changes in clinical and metabolic parameters from baseline to the end of four
           weeks fasting in Ramadan between four treatment arms:

             -  diet and lifestyle measures alone.

             -  metformin monotherapy.

             -  combination therapy with metformin + sulfonylurea.

             -  combination therapy with metformin + sitagliptin.

        -  To compare the 24 hour CGMS profile during Ramadan fasting in type 2 diabetic patients
           before and after addition of acarbose to these pre-existing sub-maximal hypoglycaemic
           regimens.
    
  